Up and coming Stanford MBA Joe Paskudnik arrived at his place of work, Good Pharma
Headquarters, on a rainy day in April, only to learn that he had been fired. As the guards hustled
him out of the building he recalled, ruefully, his boss one day muttering to him, while patting him
on the back, “Joe, you’re going to go far.” Now, he thought, with a measure of bitterness,”Yeah,
out the front door!” After all, he was not solely responsible for the failure of Good Pharma’s
new drug, elixerfor, widely touted as a permanent cure for Uneasiness, that nearly brought the
company to its knees.
Joe was assigned to shepherd the progress of the drug through development, test and
manufacturing, and herding it through fast-track approval by the Food and Drug Administration,
astutely planned for year-end, when the atmosphere tended to be more jovial at the Agency.
Upon receiving approval of the drug for distribution, Joe immediately put into effect
a plan that he had prepared in advance for a blow-out introduction of elixerfor to the public.
America’s premier drug pushers, MSNBC and CNN, were extremely cooperative in opening up prime time spots, sensing, no doubt, the million dollar opportunities that lay ahead. Television screens were filled with advertising, featuring a thinly clad girl with pretty lips reclining on a pink bed, though it was never clear what the connection was to the malady. The ads were always concluded with ass-covering litanies of call-your-doctor side effects, ranging from hair loss to kidney failure to impotence to fits of anger and desperation.
a plan that he had prepared in advance for a blow-out introduction of elixerfor to the public.
America’s premier drug pushers, MSNBC and CNN, were extremely cooperative in opening up prime time spots, sensing, no doubt, the million dollar opportunities that lay ahead. Television screens were filled with advertising, featuring a thinly clad girl with pretty lips reclining on a pink bed, though it was never clear what the connection was to the malady. The ads were always concluded with ass-covering litanies of call-your-doctor side effects, ranging from hair loss to kidney failure to impotence to fits of anger and desperation.
Copious samples of the drug were sent to sales representatives to deliver to physicians in
their respective territories. Joe himself hit the road to visit physicians of his acquaintance at their
offices in California, carrying satchels filled with samples of elixerfor.
It was a storybook introduction. Good Pharma was overwhelmed with the success of their
product. Favorable comments poured in. Joe Paskudnik was promoted to Vice President, and
moved to a top-floor office. A general feeling of well-being reigned far and wide. Good Pharma
stock soared in value. Christians partied with Muslims.
Then the debris hit the fan, as it were. Automobile drivers who had driven for some time
were prone to severe attacks of vertigo, definitely an unsafe condition when driving at high
speeds. The serial collisions and subsequent pileups were memorable. When the cause was finally traced to elixerfor, Good Pharma stock plummeted. The company found itself compelled to
underwrite auto insurance companies, who were, naturally, besieged by claims.
Disconsolate, Joe Paskudnik spent days brooding and draining six-packs in his Manhattan apartment, his girlfriend, Petunia Sidewinder, by his side.
“What will you do?” Petunia asked.
“Reboot, I guess. I don’t know anything else. Think I’ll head West. My sister lives in
California. There’s a start-up in San Diego with a new drug that cures Apathy. I believe I can
help them.”
-Edward Hujsak
-Edward Hujsak
No comments:
Post a Comment